Investor profile for Enza Capital III LP (AI Africa Fund) — 2026 first close: reported initial check, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Enza Capital III LP (AI Africa Fund) — 2026 first close check size, stages and portfolio

Africa-focused AI venture fund reported at $21M first close on November 10–11, 2026, versus a $60M fundraising target and $80M hard cap. Plans $250,000–$3M initial investments from pre-seed through Series B with the first deployments expected in 2027. Named LPs and fee terms undisclosed.

Keep track of Enza Capital III LP (AI Africa Fund) — 2026 first close

Save this profile to your VCT watchlist for a quick return.

View watchlist

Reported initial check

$250K–$3M

The firm has published this range.

New Fund III initial cheque range, not GP general size; no LP subscriptions published.

Source: trusted-media Confidence: 96% Verified: November 12, 2026 View methodology

Investment stages

Leads: Pre-Seed, Seed, Series A, Series B

Participates: Pre-Seed, Seed, Series A, Series B

Sector focus

Not recorded

Geography

Pan-Africa; GP offices Nairobi, Cairo and Johannesburg

Founded Not recorded

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

None yet

Linked startup profiles

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

VCT investor research

Inside Enza Capital III LP (AI Africa Fund) — 2026 first close's investment strategy

Independent, source-backed analysis of who the firm backs, deal evidence and whether it fits your stage.

How much has actually closed?

The Enza Capital III LP / AI Africa Fund reached $21M of first-close commitments, announced November 10–11, 2026. That is 35% of its $60M target; its $80M hard cap is an upper future fundraising ceiling, not money already raised. Exact legal closing day was not disclosed. A final close is targeted for 2027, as are initial portfolio investments. See the original GP statement as relayed by Bloomberg and Africa Private Equity News.

Mandate, investor fit and economics

The vehicle targets AI-native and AI-enabled companies across Africa, from pre-seed through Series B, including finance, healthcare, enterprise, education, climate, agriculture and infrastructure. New first cheques are $250,000–$3M, with follow-on reserves. These are Fund III parameters; the manager's broader investment criteria allow larger first cheques in different vehicles. The firm has described 49 investments across 10 countries and a 2025 Quro Medical exit from Fund I/II, which provide historical context, not Fund III realised performance. The GP has not named LPs, disclosed individual subscriptions, fee and carry terms, ownership targets or the legal first-close day.

Illustrative founder and LP journey

  1. A founder identifies an African AI-supported market problem with measurable buyer demand and checks stage/sector fit.
  2. The founder presents team credentials, evidence of usage/revenue and data/AI compliance for GP diligence; the general manager states about 2.5 months for lead equity financing on average.
  3. Funding terms depend on each negotiated round; the public new-fund initial-cheque range is $250,000–$3M, with no standard valuation or mandatory lead percentage published.
  4. Subsequent follow-on investment requires further GP approval and capacity; a follow-on reserve is not a guarantee.
  5. An LP commits capital across fundraising closes; the GP calls and deploys over time. A $21M first close is commitments, not $21M already invested in startups. Retail eligibility/LP minimum investment and terms are undisclosed.

Arithmetic check — illustration, not a business plan

At the maximum $3M initial cheque, seven fully sized investments would use $21M before fees and reserves. Actual initial investments could be smaller, capital invested later and further fundraising occur; no company-count target can be reliably inferred.

Source confidence: Bloomberg reported the manager's own emailed statement on Nov 10, while specialist outlets repeated it. This is a GP-originating disclosure as reported by media, not independent LP confirmation. No direct GP Fund III press page or LP letter was identified.

Sources and verification

Dated company disclosures take priority over third-party databases. These sources support the analysis above.

Rounds they lead

Pre-Seed Seed Series A Series B

Rounds they invest

Pre-Seed Seed Series A Series B

Last verified: 2026-11-12. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.